Daily aspirin reduced by 55% the risk of cancer recurrence in patients whose colorectal cancer is driven by a genetic ...

Research highlights aspirin’s potential in lowering tumor return by 50% in patients with specific genetic mutations - Anadolu ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients with PIK3 pathway alterations.

A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

Emerging evidence suggests a better option already exists. A recent meta-analysis by an international team of cardiologists finds that clopidogrel – which stops blood platelets from clumping – is a ...

Scientists have demonstrated that a common blood thinner is more effective than aspirin—and just as safe—for patients with ...

Early P2Y12 monotherapy after PCI for acute coronary syndrome was not noninferior compared with dual antiplatelet therapy ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...

Among adults with chronic rhinosinusitis with nasal polyps, asthma and NSAID-exacerbated respiratory disease, aspirin after desensitization does not benefit most patients vs. placebo, according to ...